Beacon Resources
All the latest news, content, webinars and insights from the Beacon Team.
Home > Resource Center
Latest Content
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ImmuneTolerance_Feature_Image.jpg)
H1 2024 Immune Tolerance Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Bispecific_Feature_Image.jpg)
H1 2024 Bispecific Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Beacon-RNA-H1-2024-Featured-Image.png)
H1 2024 RNA Landscape Review
Webinars
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ADC-7.png)
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/A-Review-of-the-Induced-Proximity-Landscape-1.png)
Beacon TPD: Induced Proximity Landscape Review 2024
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CT-2.png)
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
ADC
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ADC_Feature_Image.jpg)
H1 2024 ADC Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ADC-7.png)
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/BsADCs-Featured-Image.png)
Unlocking the Potential of Bispecific ADCs
Bispecific
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Bispecific_Feature_Image.jpg)
H1 2024 Bispecific Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/BsADCs-Featured-Image.png)
Unlocking the Potential of Bispecific ADCs
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Cancer Vaccine
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/WordPress-Featured-Image-5.png)
Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CV-2.png)
2023 Cancer Vaccine Landscape Review
Cell Therapy
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CellTherapy_Feature_Image.jpg)
H1 2024 Cell Therapy Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/CT-2.png)
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Checkpoint
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Checkpoint_Feature_Image.jpg)
H1 2024 Checkpoint Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ASCO-Infographic-Featured-Images-1.png)
ASCO 2024: Checkpoint Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Cytokine
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Cytokine-ASCO-Infographic-2024-Featured-Image.png)
ASCO 2024: Cytokine Highlights
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Cytokine-DC-Report-Featured-Image.png)
Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization
DDR
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/6315_Beacon_2024_Campaign_DDR6.png)
The 2024 DDR H1 Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Featured-Images-.png)
Beacon DDR: ASCO Post-Conference Report 2024
Gene Therapy
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/GeneTherapy_Feature_Image.jpg)
H1 2024 Gene Therapy Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-4.png)
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Immune Tolerance
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ImmuneTolerance_Feature_Image.jpg)
H1 2024 Immune Tolerance Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-5.png)
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
Microbiome
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/MB-TOI-Digest-Featured-Image.png)
Microbiome: US Market and LBP Development
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Featured-Images-1.png)
Microbiome: Drug Development in Asia Infographic
Oncolytic Viruses
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/WordPress-Featured-Image-6-e1717692135998.png)
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/OV-1.png)
2023 Oncolytic Viruses Landscape Review
RNA
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Beacon-RNA-H1-2024-Featured-Image.png)
H1 2024 RNA Landscape Review
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-4.png)
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
TPD
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Feature-Cover-9.png)
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/Featured-Images-1-1.png)
Beacon TPD: ASCO Post-Conference Report 2024
![](https://cdne-bcnwp-neu-prd.azureedge.net/wp-content/uploads/ASCO-2023-.png)
TPD: AACR Post-Conference Report 2024
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.